Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer

Conditions:   Breast Cancer;   HER2-negative Breast Cancer;   Node-negative Breast Cancer;   Breast Carcinoma Interventions:   Drug: Anastrozole 1mg;   Drug: Letrozole 2.5mg;   Drug: Exemestane 25 mg;   Drug: Tamoxifen Sponsor:   Emily Marcinkowski Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials